B. Johansson

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

Sergi Ferré, Gabriel von Euler, B. Johansson et al. · Proceedings of the National Academy of Sciences · 1991 · 549 citations · Full text

Adenosine Antagonist, Neurotransmitter, Pharmacotherapy +19

Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors

Rodrigo A. Cunha, M. Dolores Constantino, A. M. Sebasti�o et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1996 · 183 citations

Rat Hippocampus, Molecular Pharmacology, Neurophysiology +12

Tenth International Workshop on Human Gene Mapping

Joseph D. Tucker, Morten Lykkegaard Christensen, A.V. Carrano et al. · Cytogenetic and Genome Research · 1988 · 144 citations · Full text

Genetic Analysis, Functional Genomics, Genetics +5

Synthetic antagonists of the myometrial response to vasopressin and oxytocin

Per Melin, Jerzy Trojnar, B. Johansson et al. · Journal of Endocrinology · 1986 · 133 citations

Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number

Vasil Georgiev, B. Johansson, Bertil B. Fredholm · Brain Research · 1993 · 99 citations

Long-term Caffeine Treatment, Nmda-induced Clonic Seizures, Neurophysiology +12